Health Archive » January, 2023

Health - January, 2023

415 articles

• DEA Faulted Controls At Opioid Distributors, Ga. Jury Hears
• DC Circ. Revives FOIA Suit Seeking Execution Drug Info
• Amgen, Horizon Say FTC Is Reviewing Proposed $28B Merger
• Center Booted Doctor Who Raised Safety Issues, Suit Says
• Title 42 Suits May Die Alongside Nat'l Emergency
• J&J's Case Axed, But Door Not Shut On 'Texas 2-Step' Ch. 11s
• Vitamin Biz Agrees To $22.8M Deal To End Customs Fraud Suit
• Magistrate Recommends Not Tossing CBD Suit Counterclaims
• Riding Circuit: February's Notable Oral Arguments
• Gov't Contracts Of The Month: Green Planes And Army Trucks
• Meta Cites Privacy In COVID Misinformation Subpoena Fight
• Addressing The Perils Of Contractor Teaming Arrangements
• COVID Testing Countersuit Against BCBS Unit Trimmed
• Calif. Pot Regulators Ask State AG About Interstate Pot Trade
• Optical Co. Hid Optometrist Staffing Woes, Investor Claims
• What 2023 Has In Store For The Cannabis Industry
• Florida Doctors Convicted In $31M Medicare Fraud Scheme
• 9th Circ. Should Rethink Inadequate UBH Ruling
• Wash. Insurance Chief Unaccountable For Conduct, Staff Says
• Fed. Circ. Nixes Quinn Emanuel's $185M Fee In ACA Cases
• Dallas Nursing Home Operator Gets OK For Ch. 11 Plan
• Biotech Goosed Stock With Omicron Vax Claims, Suit Says
• Opioid Victim Families Go To Trial Against Distributors In Ga.
• Feds Call Convicted Theranos COO Balwani A 'Flight Risk'
• White House To End COVID-19 Emergency Declarations In May
• 'Many Legal Challenges' Loom As HHS Inks $4.7B Audit Rule
• Bernstein Litowitz Nabs $7.7M Fees In Stericycle Case
• Ex-Outcome Health Execs' Greed Led To $1B Fraud, Jury Told
• Canadian Pharma Co.'s Units File $61M Ch. 15 In Delaware
• New ACA Birth Control Exemptions Cover Faith, Not Morality
• Walgreens To Pay $7M In FCA Suit Over Hepatitis C Drugs
• Michigan Firm Pushes Judge To Ax Debt Collection Case
• Ex-Hunter Prof Owes US For Scuba Trips Billed As HIV Work
• HHS Can't Force 'Unlimited' Drug Discounts, 3rd Circ. Says
• 9th Circ. Lets Idaho Trans Women Sports Ban Fight Continue
• Troutman Pepper Adds Commercial Real Estate Partner
• Surgical Practice Drops Monopoly Suit, Hits Snag Over Fees
• Doctor's Misstep Ended Ex-Eagle's Football Career, Jury Told
• Blue Cross Improperly Withheld Claims Data, Mich. Tribe Says
• First Wave BioPharma Director Sues For Legal Fees In Del.
• Catching Up With Delaware's Chancery Court
• Pot Co. Trulieve Hit With ADA Suit Over Denied Promotion
• Mich. Doctor Gets 16 Years For $100M Opioid Pill Scheme
• Mass. Launches Abortion Hotline Staffed By BigLaw, ACLU
• NY Hospital's Vax Firing Violated Bias Laws, Worker Says
• 3rd Circ. Throws Out J&J Talc Unit's 'Texas Two-Step' Ch. 11
• 11th Circ. OKs FTC Asset Freeze In Fla. Health Care Scam
• Texas High Court Will Hear Doctor's Obesity Bias Case
• Pharma Co. Hit With 2nd Suit Over $1.8B AstraZeneca Deal
• Sen. Warren Wants FTC Scrutiny Of $29B Pharma Deals
• Phone Consult Enough To Sue Ill. Doctor For Malpractice
• Parents Can't Seek Future Wages In Infant Death Suit
• Benefits Co. Can't Escape J&J's Suit Over Patient Drug Fund
• Texas Police Dept. Fired Officer After C-Section, Suit Says
• Generic Zantac Makers Want Final Judgment In Fla. MDL
• Esformes Asks 11th Circ. To Rehear Case, Toss Indictment
• Surgeon's Guilt In $31M Fall Scam 'Overwhelming,' Feds Say
• Texas Supreme Court To Take On Anti-Mask Mandate Fights
• Publix Excess Insurers Look To Sink Opioid Coverage Claims
• Sunscreen Maker Can't Nix 'Reef Friendly' False Ad Suit
• Ohio Hospital Says Ex-CEO's Firing Didn't Require Hearing
• 9th Circ. Backs Biden's Power To Fire NLRB General Counsel
• Pharma Co. Appeals Malpractice Loss Against Polsinelli
• 5 Ways Attorneys Can Use Emotion In Client Pitches
• Pharma Whistleblower Asks 2nd Circ. To Revive Kickback Suit
• GAO Rejects Protest Of $80M CMS IT Support Deal
• Ga. Health Care System Wants To Clip $4.6M ERISA Suit
• Mich. No-Fault Reform Isn't Retroactive, Panel Says
• California Exec Convicted Of $157M Drug Scheme
• Taylor Wessing Pursues 'Strategic Alliance' With Madrid Firm
• 9th Circ. Rules UBH Doesn't Have To Reprocess 67,000 Claims
• Investors Say Cannabis REIT Should Have Known About Ponzi
• 6th Circ. Vexed By Ex-Smuckers Workers' COVID-19 Vax Suit
• Ariz. Tribe Sues McKinsey Over Opioid Crisis
• NC Dems Defy GOP Majority With Bill To Codify Roe V. Wade
• RFK Jr.-Repped Doc Wins Halt Of COVID Misinformation Law
• NC Judge Kicks Claim After Doctors Call In 2 States' Laws
• PTAB Upholds Testing Patents After Ravgen's $272M Jury Win
• Zantac Suits Consolidated In NY After Fla. MDL Tossed
• Pa. Nursing Home Hit With $19M Verdict In Death Suit
• Teva Can't Get HHS Docs For Kickback Defense
• New Compensation And Benefits Rules Demand Early Action
• FCC Aims To Improve Outage Reporting For 988 Hotline
• In Blow To Hemp Industry, FDA Punts On CBD Rules
• AstraZeneca Sales Reps See Pay Bias Suit Axed, For Now
• SPAC Buys Longevity In $236.2M Deal Led By 2 Firms
• 5 Keys To A Productive Mediation
• Investor Sues For Docs On $300M Stake In Script Relief
• FCC Reworks Payment Model For Rural Health Connectivity
• 10th Circ. Wants Feds' Input In Oklahoma PBM Lawsuit
• Pfizer Bid To Shield FBI Talks Meets Skeptical Judge
• DC Circ. Questions FDA Appeal Process In E-Cig Case
• NC Trans Care Exclusion Draws Tough Questions At 4th Circ.
• Jury To Decide If Allergan Sale Included Arbitration Clause
• Fla. Court Axes Punitives In Fatal Brain Injury Med Mal Suit
• Personal Injury Atty Won't Pay Client's Medical Bill, Suit Says
• Regeneron Gets Novartis Syringe Patent Axed At PTAB
• Nurse Fired After Reporting Racist Remark, 11th Circ. Told
• Shareholders Sue Sotera After $363M Emissions Verdict
• 6th Circ. Judge 'Baffled' By 'Casual' Mich. Mistrial Decision
• Abortion Drug Restrictions Draw Challenges In W.Va., NC
• Preparing For An Era Of Regulated Artificial Intelligence
• Nurses Secure $1.3M Settlement In Pandemic Overtime Case
• Real Estate Rumors: Krakoffs, Avondale Care, MKB Ventures
• Coverage Fight Over Inmate Death To Remain In Federal Court
• GAO Nixes $52M IT Award Over 'Unsupported Assumptions'
• Juul MDL Paused As 9th Circ. Reviews Class Certifications
• Calif. Dentistry Owes $2M In Unpaid Employment Tax, US Says
• Signify Health Sued In Del. For Breach Of $300M Merger Deal
• Horse Trainer Gets 5 Years In Doping Scheme
• Ex-DOJ Prosecutor, FCA Expert Rejoins Crowell & Moring
• Rare COVID Benefits Award Yields Workers' Comp Road Map
• Gilead Wants US To Face Defenses Before HIV Patent Trial
• Deal Caps DOJ's 1st Win In Individual No Poach Criminal Case
• Feds, Catholic Group Urge 8th Circ. To Rehear Trans Ruling
• Indian Hair Care Co. Says Ohio Court Can't Hear Cancer Case
• NLRB, Union Urge 3rd Circ. To Back Hospital Disclosure Order
• New Clinical Trial Law Promotes Diversity And Modernization
• Save Mart Seeks Checkout From Retirees' Benefits Suit
• Investor Files Securities Suit Over $952M Albireo Merger
• Ex-Olympic Skater Pleads Guilty To COVID Relief Fraud
• Purdue Warns Tribe's NY Lawsuit Could 'Blow Up' Ch. 11 Plan
• Real Estate Rumors: UBS, Bridge Industrial, Amzak
• DOD, Ex-Sergeants Spar Over Dismissal Of Vax Mandate Row
• Philly Boutique Adds Ex-Prosecutor To Whistleblower Practice
• Procter & Gamble Duped DayQuil, Vitamin C Buyers, Suit Says
• FCC Clarifies How Agencies Can Make Medicaid Calls
• Insurer Can't Slip Mental Health Coverage Suit
• Reed Smith Opens Orange County Office, Firm's 5th In Calif.
• GAO Clears Booz Allen's $860M Deal Of Conflict Claims
• 1st Circ. Reels Aetna Back Into Knee Implant Libel Suit
• Ariz. Tribal Hospital, IHS Reach Settlement In Funding Spat
• Kroger Seeks Insurance Coverage For Over 700 Opioid Suits
• Holmes Says Feds' Claims Of Mexico Escape Plans Are False
• Pharma Co. Faces Investor Suit Over $1.8B AstraZeneca Deal
• 9th Circ. Won't Rehear Wash. Ban On Gay Conversion Therapy
• UMiami Exec Loses Retrial Bid In Hospital Billing Firing Suit
• Florida Justices Agree To Hear Challenge To Abortion Law
• Navajo Nation Drops Long-Standing Mask Mandate
• FTC Fines LasikPlus Clinics $1.25M For Deceptive Advertising
• Stoel Rives Adds 2 Ex-Perkins Coie Lawyers In Portland
• 11th Circ. Backs Fla. Man's Medicare Fraud Conviction
• Philly School District Sues Over New City Asbestos Rules
• Court Consolidates Takeda Antitrust Suits Over IBS Drug
• Ex-Jones Day Staffer Out Of Benefits, Unum Says In Bias Suit
• Bard Vascular Filter Case In Georgia Settles On Eve Of Trial
• High Court Won't Take On SEIU Union Dues Deduction Suit
• Sotera VP Sues In Del. For Legal Fees After Toxic Tort Deal
• Evaluating The Legal Ethics Of A ChatGPT-Authored Motion
• After Catalyst Case, FDA Won't Stop Approving Orphan Drugs
• PPP Loans Irrelevant In Wage-Fixing Trial, Court Told
• Md. Appeals Court Upholds Recall Of Marijuana Chocolates
• Ex-Pro's Issues Predated His NFL Days, Benefits Plan Says
• Velsicol Must Face Suit Over Pesticide Made By Predecessor
• Kratom Co. Asks 11th Circ. To Nix 'Naked License' Ruling
• Catching Up With Delaware's Chancery Court
• Justices Decline Ex-Walmart Pharmacist's Race Bias Case
• Former Troutman Pepper Attys Launch Goodwin Philly Office
• Texas Pain Clinic Says Personal Injury Attys Never Paid Up
• Juul's $255M Economic Loss MDL Deal To Get Green Light
• Brand Battles: Uber Tries To Drive Out 'Uberhorny' Dating TM
• GAO Says Protester's Bid For $25M Deal Lacked Details
• Red States Back VA Nurse Contesting Biden's Abortion Rule
• BCBS Unit Sues Insurer For Coverage In $2.7B Antitrust Deal
• Calif. AG Greenlights $14M Residential Care Facility Sale
• IHS Proposes Expansion Of Wash. Tribe's Coverage Area
• J&J Unit DePuy Pays $9.75M Over Spinal Implant FCA Claims
• FTC Wants Shkreli Held In Contempt Over Stonewalling
• 4th Circ. Revives Investment Co. Founder's Insurance Suit
• Mich. Appellate Panel Refuses To Revive Flint Criminal Cases
• Albright Scratches Patent Claims In Website Data Spat
• Hospital Beats Disability Bias Suit Over Intern's Service Dog
• FCC Urged To Keep Telehealth Rates' Status Quo For Now
• Cannabis And Psychedelics Roundup: Virginia Bill Goes Down
• AndroGel Patent Suit Ruled Baseless For Antitrust Claims
• Focus On Drug's Cancer-Killing Potential, Judge Tells Biotech
• Lessons On Prior Art From PTAB's Genetic Testing Decisions
• HHS Vows Audits, Publicity Targeting Nursing Home Practices
• Pharmacy Owner Convicted Of Paying $25M In Kickbacks
• Ex-CytoDyn CEO Sues In Del. Chancery Court For Legal Fees
• Defense Wants 'Rule-Breaking' Plaintiffs' Attys Off Wage Case
• Feds Say Elizabeth Holmes' Flight Risk 'Never Been Higher'
• NJ Judge Signs Off On $1.3M Atty Fee In Immunomedics Suit
• 7 Tips To Increase Your Law Firm's DEI Efforts In 2023
• UK Litigation Roundup: Here's What You Missed In London
• Keys To A 9-0 High Court Win: Get Back To Home Base
• High Court Legacy Of FCA Unity Teeters On Ideological Brink
• 3rd Circ. Affirms Drug Testing Lab's Escape From TCPA Suit
• Feds Want Negligence Claim Cut In Chickasaw Medical Suit
• 9th Circ. Backs Ex-University Worker's 1st Amendment Claim
• Ohio Home Health Co. Hit With Overtime Class Action
• 4th Circ. Says ACA Payment Is Tax For Bankruptcy Purposes
• PPE Fraud Suit Ends In $2.1M Judgment For Fla. Reseller
• Juul Investor Seeks Limited Scope In April Vaping Trial
• J&J Unit Takes Aim At Doctors Linking Talc To Mesothelioma
• No Atty Fees For NC Doctor In Biz Spat With Former Practice
• Indian Drug Distributor Gets 7 Years For Trafficking Pills In US
• Incorrect Inventorship On Patents Is A Tough Claim To Prove
• Feds Say Texas Vax Suit 'Moot' After Mandate's End
• NYC Mayor Defends Vax Mandate As 2nd Circ. Mulls Appeal
• Goodwin Adds Former Chief Counsel Of Health Agency's OIG
• Endo Gets Approval For Fee Deal With State Governments
• Justices Seek Feds' Input In Ex-Shkreli Atty's 401(k) Fight
• Supreme Court Says It Hasn't Identified Dobbs Leaker
• California Siblings' Death Suit Tossed Over Late Filings
• AMC Resolves Lawsuit Claiming It Blacklisted Set Medic
• Squire Patton Adds Ex-Senior DOJ Fraud Atty In DC
• Dallas Nursing Home Reaches Creditor Deal In Ch. 11 Plan
• Patients Seek Class Cert. In Cigna Benefits Underpayment Suit
• 9th Circ. Backs Culver City's COVID-19 Hazard Pay Win
• NJ Judge Blocks Township's Ambulance Services Ordinance
• The 7th Circ.'s Top 10 Civil Opinions Of 2022
• Walmart Aims To 'Weaken' Opioid Script Laws, DOJ Says
• Investors, Inovio Get Final OK For $44M Deal In Stock Suit
• NJ Panel Rules Agency Phones Off Limits In Health RICO Case
• Atty-Client Privilege Arguments Give Justices A Moving Target
• 7th Circ. Upholds Indiana Hospital's Win In Race Bias Suit
• Jazz Pharma Unit Sues Over Cannabis Seizure Drug Patent
• Insurer Tells 4th Circ. No Fraud Coverage Owed To Practice
• W.Va. AG Inks $83M Opioid Deal With Walgreens
• Justices Ignite FCA Debate: Fairness Vs. 'Invitation To Fraud'
• FDA Urges Texas Judge Not To Reverse Abortion Pill Approval
• Fed. Circ. Urged Not To Reverse Jazz's Orange Book Delisting
• NC Court Throws Out Suit Over Doc's Bawdy Farewell Bash
• Judge Probes DOJ Team After Health Care Fraud Mistrial
• 11th Circ. Hints CDC Mask Mandate Procedurally Flawed
• Med Center May Have Coverage Despite Unlicensed Doctors
• Calif. Wants High Court To Toss $302M J&J Mesh Fine Appeal
• Mich. County Loses Challenge To $800M Opioid Payout Plan
• 5 Gen X Characteristics That Can Boost Legal Leadership
• 10th Circ. Skeptical Of Forcing Arbitration In ESOP Row
• Catching Up With Delaware's Chancery Court
• Ga. County Asks 11th Circ. To Nix Trans Discrimination Ruling
• DC Health Care Co. To Pay $1.5M For Shorting Pandemic Staff
• Mallinckrodt Ruling Holds Creditor Lessons For IP Sellers
• Commerce Issues Export Curbs On Marine Toxins
• Endo Claimants Say It's Time For Alternative Ch. 11 Plans
• Human Trafficking Orgs. Tell High Court To Eye Nurses' Case
• Pharmacies And Drug Cos. Want Out Of Texas Opioid MDL
• Attorneys See Sober Outlook For Deals After JP Morgan Event
• What To Expect From Justices' FCA Scienter Standard Review
• Voyager Sells Digital Assets For $1B, FTX Finds $5B In Crypto
• 6th Circ. Slams Door On Wholesaler's Opioid Coverage Fight
• New Ill. Law Aims To Protect Out-Of-State Abortion Patients
• Law360 Names Practice Groups Of The Year
• Predictions For The 2023 Drug Pricing Landscape
• Bausch Hits Aurobindo With Gastro Drug Patent Suit
• 6 Questions For Boutique Firms Considering Mergers
• Rubber Co. Fights Bid To Toss Hidden Labor Violation Suit
• Instacart To Pay $5.25M To Halt San Francisco Benefits Probe
• Supreme Court Will Scrutinize FCA's Scienter Standard
• 10th Circ. To Mull Forced Arbitration Of ERISA Class Actions
• Atty Fee Requests In School Masking Cases Fail At 3rd Circ.
• Pipeline Health Gets OK For Plan To Cut $330M In Debt
• MRI Co., Receptionist Reach Deal To End Discrimination Suit
• Devereux Foundation Can't Trim Claims From Abuse Suit
• UK Litigation Roundup: Here's What You Missed In London
• 'I've Had My Fill,' Ill. Judge Says In Express Scripts Suit
• VA Looks To Waive Most Health Care Copays For Native Vets
• Calif. Says Insulin Makers, PBMs Overcharge Diabetics
• Wash. Tribes Owed Medicaid Funding, 9th Circ. Rules
• Nursing Home Creditors Say Ch. 11 Fee Budget Too Small
• Texas High Court Mulls Over Health Nondisclosure To Insurer
• Before Insurance Trial, Duke Seeks $16M For Antitrust Suits
• Elder Care Facility Not Covered For Death Suit, Insurer Says
• Mich. Justices Probe Insurer's Standing To Question Clinics
• 3rd Circ. Presses US On Mylan's $50M Tax Bill For Court Costs
• 8th Circ. Rejects Car Crash Suit Involving Rosebud Sioux Man
• NYC Retirees Granted Block On Health Care Copays
• Paramedical Services Co. Settles TCPA Suit Over Robocalls
• 11th Circ. Says Atty Not To Blame For Medicare Fraud Verdict
• Deals Rumor Mill: Microsoft, Subway, Goldman Sachs Layoffs
• Nurses End Strike At 2 NYC Hospitals After 3 Days
• NM Hospital Patients Get Initial OK For Data Breach Deal
• Groups Sue Media Over 'Antitrust Boycott' Of Disinformation
• Acorda Says It's Owed $65M More In MS Drug Fight
• Astellas Sues Chinese Rival To Block Generic Bladder Drug
• Walgreens Overcharges For Kids' Cough Medicine, Suit Claims
• AHA Backs Sutter Health Volume Insurance Deals To 9th Circ.
• 6 Takeaways From LabSolutions 'Unnecessary Testing' Verdict
• Ohio Pharma Board Must Reconsider Dispensary Application
• Mo. High Court Vacates $5M Geico Payout In HPV Suit
• 5 Charged With Defrauding Gov't-Funded Child Care Programs
• Judge Pushes Resolution In Vanda, FDA Gastro Drug Fight
• Ga. Justices Won't Review Pipe Fitter's Asbestos Suit
• Fennec Sues Cipla Over Generic Hearing Loss Treatment Bid
• The Issues Shaping Labor Market Antitrust Litigation In 2023
• Magellan Health Blasts 'Bravado' Of Fee Bid In Chancery Case
• How Ohio Software Ruling Implicates Crypto Insurance Claims
• Food Truck Owner Cops To $1.5M Pandemic Relief Fraud
• 11th Circ. Backs Care Co.'s Win In Ex-Director's Race Bias Suit
• State Constitutions Take Spotlight Post-Dobbs
• 6th Circuit Won't Put Brakes On Ky. Securities Fraud Probe
• FDA Drug Approvals Don't Include Impurities, DC Circ. Rules
• Pending Appeal, Balwani Asks To Stay Out Of Prison
• Choctaw Nation Asks 9th Circ. To Reverse Arbitration Order
• Chancery Class Seeks Rare AmerisourceBergen Ruling Redo
• Pa. Records Office Must Review Health Dept. Pot Recall Docs
• After 2nd Circ. Ruling, Insider Trading Laws Need Clarification
• Juul Founders Must Face NY AG's Underage Marketing Suit
• Midterm Cannabis Results Remind That Progress Is Not Linear
• Cipriani & Werner Sues Aurobindo Pharma For $3.8M MDL Tab
• IQVIA Says 401(k) Class Can't Show Plan Suffered Losses
• Ex-Aegerion Rep In Talks With Feds To Avoid 2nd Fraud Trial
• Surgical Center Operator Hid Data Breach, Patients Say
• 5 Tips For Adding Value To Legal Clients' Experience In 2023
• Trucking Co.'s Docs Show Discrimination, EEOC Tells Jury
• 1st Circ. Backs GSK's Preemption Win Against Zofran MDL
• 2nd Circ. Tightens Screws On Insider Trading Prosecutions
• Endo Ch. 11 Could Stiff Future Opioid Claimants, Judge Told
• Sterigenics To Pay $408M To End Over 870 Emissions Suits
• Clorox Seeks Toss Of Water Filter Antitrust Suit
• Fla. Med Tech Co. Says Man Consented To Marketing
• 4 Key Issues Driving Drug Discount Abuse Must Be Addressed
• IQVIA Thwarts Research Co.'s Early Exit From Poaching Suit
• 9th Circ. Upholds Steel Mill's Win In Ex-Worker's FMLA Suit
• Justices Jilt Pfizer's Kickback Attack, But Dispute Isn't Done
• Real Estate Rumors: CareRite, Tribeca Associates, Incline
• RFK Jr. Faces Dubious 9th Circ. In Warren Free Speech Fight
• Geico Accuses NY Psychologists Of Car Insurance Fraud
• NY Adult Survivors Act Look-Back: What Orgs Must Know
• Catching Up With Delaware's Chancery Court
• Teva Says $4.3B Global Opioid Deal Can Move Ahead
• Bayer Whistleblower Attys Want $2.2M In Fees For FCA Suit
• Pharma Biz Sues PE Firm In Delaware, Alleging Raid On Staff
• Venable Adds Ex-Lyft Federal Policy Senior Manager In DC
• Justices Deny Texas' Bid To Revive Trump Public Charge Rule
• NJ Town Slams 2nd Appeal In Abortion Buffer Zone Fight
• 11th Circ. Affirms Health Care Fraudster Esformes' Conviction
• Greenberg Traurig Nabs Biotech IP Atty From Kasowitz
• Idaho, SC Top Courts Diverge On Abortion Access
• FDA Clears New Alzheimer's Drug Amid Lingering Controversy
• Investor Sues To Halt $615M Boston Scientific Deal
• Syrian-Born NY Doctor Says Colleagues Disparaged Arabs
• Green Groups Fight Another Bid To Delay Fluoride Risks Case
• Casino Sued By Fired Religious Worker Who Refused Vaccine
• Pending Deal, Oral Debate Paused In Trans Prof's Bias Suit
• 11th Circ. Again Denies Shire's Bid To Dodge Label Case
• Health Hires: Kymera Therapeutics, Crown Laboratories
• Tribes Ask 9th Circ. To Restore ICWA Compliance Reviews
• Health Software Firm To Go Public Via $98M SPAC Merger
• The Hottest FCA Cases & Trends To Watch In 2023
• NY Pot Regulators Report Shows Few Licenses Granted
• DOL Updates Timelines On Employee Benefits Regulation
• Home Health Care Provider Cancels $681M SPAC Merger
• Altria Accuses Juul Of Hiding Vaping Settlement Details
• CBD Drug Co. Alleges Teva, Others Violated Patents
• How Hospitals Can Adapt To Growing Challenges In 2023
• 9th Circ. Urged To Uphold Insurance Buyers' Antitrust Loss
• 11th Circ. Axes Docs' Pill Convictions After High Court Ruling
• Investor Says Biotech Co. Hid Blood Treatment Funding Woes
• Horizon Therapeutics Investor Sues To Halt $28B Amgen Deal
• Client Fights Med Mal Attys' Bid To Toss Suit Over Late Filing
• Airline Trade Group Urges 9th Circ. To Ground Ordinance
• 7th Circ. Ruling Highlights Risks Of Foreign Debt Collateral
• Nurse Agency Not Covered For Trademark Fight, Insurer Says
• Court Says Co., Execs Can Share Reed Smith Lawyers
• UAW Off Hook For Honeywell's Atty Fees In ERISA Case
• Drug Co. Execs Didn't Disclose Animal Abuse, Investor Says
• Former NJ Official Cops To Draining Benefit Program Of $4.5M
• TTAB Rejects Health Care Co.'s TM As Descriptive
• Aetna Slims Down Class Claims In ERISA Coverage Suit
• Invisalign Maker Says SmileDirect 'Built On A Lie' In New Suit
• Soldiers Face Food Insecurity More Than Civilians, Study Says
• Emory Wants Out Of Former Executive's Discrimination Suit
• Dinsmore Picks Up Ex-Middleton Reutlinger IP Pros
• 8th Circ. Tosses Doc's Suit Over Law Prof's Criticism
• Judge Scraps Skull Shaver Design Patent Case
• 9th Circ. Reverses City's Win In Sober Living Homes Suit
• FTC Blasts Data Broker Co.'s 'Preemptive' Privacy Suit
• Trinity Health Abandons Hospital Deal Despite Calif. AG's OK
• Express Scripts Antitrust Suit Is 'Off The Rails,' Judge Says
• Abbott Wins $26M Against Retailer In Test Strips TM Row
• Health Orgs Must Prepare For End Of COVID Waivers
• In Holmes' Sentencing, Judge Has Warning For All Companies
• FDA's 1st Cannabis Adviser May Mean CBD Regulation In 2023
• Ill. Doctor Can Be Sued For Post-Treatment Death, Court Finds
• 'Critical' Offer Key To Mass. Vets Home Case, Justices Say
• FDA Paves Way For Pharmacy Chains To Offer Abortion Pills
• Health & Pharma Legal Clashes Didn't Take A Holiday Break
• Conn. Hospital Group Says Residents Have No Antitrust Case
• Nurses Accuse Colo. Staffing Firms Of Pay Bait-And-Switch
• Catching Up With Delaware's Chancery Court
• Potential Upheaval For FDA Regulation Of Stem Cell Clinics
• CNA Unit Gets Staffing Co.'s Settlement Coverage Suit Tossed
• Conn. Caregivers Say Agency Owes OT For Interrupted Breaks
• Mallinckrodt Tries To Stop Another Oxide Rival
• Blue Cross Gets Michigan Claims Dropped In Monopoly Suit
• KPC Workers' Counsel Seek $3.4M For Stock Plan Settlement
• Ex-Lab Manager Says Takeda Unit Allowed Bias, Retaliation
• 6 Ways To Avoid Compounding Errors When Practicing Law
• 4 Firms Lead Med Tech, Clean Energy SPAC Deals
• Janssen Says Whistleblower Dragging Feet In Kickback Case
• Florida Legislation to Watch in 2023
• Antitrust Conduct Issues And Cases To Watch In 2023
• Bankruptcy Cases And Trends To Watch In 2023
• Retail Cases To Watch 2023
• Top 10 Whistleblowing And Retaliation Events of 2022
• Ga. Legislation To Watch In 2023
• 5 Policy Moves Benefits Lawyers Should Watch In 2023
• Health Care & Life Sciences Litigation To Watch In 2023
• Personal Injury And Med Mal Cases To Watch In 2023
• Top Product Liability Cases Of 2022
• 5 Major Wage And Hour Cases To Watch In 2023
• 2 States Take The Lead On Regulating Psychedelics
• Health & Life Sciences Attys Share Policy Predictions For 2023
• 5 ERISA Cases To Keep An Eye On In 2023
• California Cases To Watch In 2023
• Trials To Watch In 2023
• Georgia Cases To Watch In 2023
• What Will Keep Legal Talent Professionals Up At Night In 2023
• The Cybersecurity Stories That Could Define 2023
• Gov't Contracts Cases To Watch In 2023
• Top 4 Gov't Contracting Policies To Watch In 2023
• Texas Legislation To Watch In Early 2023